Soluble CD36 levels have been reported not only in patients with carotid stenosis and unstable atheromatous plaque but also in chronic inflammatory related states such as diabetic nephropathy, polycystic ovary syndrome, and severity of hepatic steatosis and insulin resistance and individuals with morbid obesity [47–50]. This evidence concerns the gene CD36 and diabetic kidney disease.